See also this year's filing and all EDGAR filings for this company.
PDF Report 0001012477_2024_Avadel_Pharmaceuticals_PLC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001012477, Avadel Pharmaceuticals PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 134,202,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 16,836,000 |
| 2 | PropertyPlantAndEquipmentNet | 585,000 |
| 3 | remainder_Assets | 13,075,000 |
| 4 | LiabilitiesCurrent | 36,855,000 |
| 5 | LiabilitiesNoncurrent | 7,344,000 |
| 6 | remainder_Liabilities | 32,760,000 |
| 7 | CostOfGoodsAndServicesSold | 1,464,071 |
| 8 | SellingGeneralAndAdministrativeExpense | 214,064,034 |
| 9 | ResearchAndDevelopmentExpense | 10,792,340 |
| 10 | remainder_Expenses | 12,711,428 |
| 11 | remainder_Revenues | 28,285,743 |
| 12 | remainder_NetIncome | -9,378,655 |
| 13 | remainder_ComprehensiveNetIncome | 1,427,993 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 164,698,000 |
| 1 | Liabilities | 76,959,000 |
| 2 | Expenses | 239,031,873 |
| 3 | Revenues | 28,285,743 |
| 4 | StockholdersEquity | 87,739,000 |
| 5 | NetIncome | -220,124,785 |
| 6 | ComprehensiveNetIncome | -219,410,788 |
| 7 | BaseVar | 259,890,632 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.233 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
